No abstract

Electrochemical carbon dioxide reduction reaction (CO2RR) refers to the conversion of carbon dioxide into compounds with added value through electrolysis. It is still a great challenge to design and manufacture efficient CO2RR catalysts for desired products. Producing syngas via CO2RR is an environmentally friendly way to reduce CO2 in the atmosphere and the dependence on fossil fuels. Herein, a new class of Cu/In2O3 nanoparticles (NPs) with controlled phases and structures were successfully prepared as superior electrocatalysts for CO2RR, where the CO/H2 ratios in syngas on Cu/In2O3 NPs/C−H2 remained about 1 : 2 at a broad potential range and the total faradaic efficiency of H2 and CO always remained about 90 %. Electronic structural analysis revealed that the excellent performance was attributed to the electronic interaction between amorphous In2O3 and Cu. This work broadens the horizons for designing and preparing fascinating electrocatalysts for CO2RR.

Prevention and early intervention are the current focus of treatment for Alzheimer's disease (AD). An increase in reactive oxygen species (ROS) is a feature of the early stages of AD, thus suggesting that the removal of excess ROS can be a viable method of improving AD. Natural polyphenols are able to scavenge ROS and thus promising for treating AD. However, some issues need to be addressed. Among them, important are that most polyphenols are hydrophobic, have low bioavailability in the body, are easily degraded, and that single polyphenols have insufficient antioxidant capacity. In this study, we employed two polyphenols, resveratrol (RES) and oligomeric proanthocyanidin (OPC), and creatively grafted them with hyaluronic acid (HA) to form nanoparticles to address the aforementioned issues. Meanwhile, we strategically grafted the nanoparticles with the B6 peptide, enabling the nanoparticles to cross the blood–brain barrier (BBB) and enter the brain for AD treatment. Our results illustrate that B6‐RES‐OPC‐HA nanoparticles can significantly scavenge ROS, reduce brain inflammation, and improve learning and memory ability in AD mice. B6‐RES‐OPC‐HA nanoparticles have the potential to prevent and alleviate early AD.

No abstract

No abstract